检索历史清除

首页> European urology> External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone

External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone

导出原文传递

翻译打印收藏纠错

作者： Ravi,P. ^[1] ; Mateo,J. ; Lorente,D. ; Zafeiriou,Z. ; Altavilla,A. ; Ferraldeschi,R. ; Sideris,S. ; Grist,E. ; Smith,A. ; Wong,S. ; Bianchini,D. ; Attard,G. ; DeBono,J.S.

作者单位： Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom ^[1]

关键词 Abiraterone Castrate-resistant prostate cancer Prognosis

发布时间 2018-08-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交